Nordson Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NDSN research report →
Range $345 – $375
Price Chart
About the company
Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment.
- CEO
- Sundaram Nagarajan
- IPO
- 1980
- Employees
- 8,200
- HQ
- Westlake, OH, US
AI snapshot
Six angles, distilled from the data.
The stock sits in a mature uptrend, trading above its 200-day moving average and not far from its 52-week high. That keeps the long-term regime constructive, though the recent pullback from the upper end of the range suggests momentum is consolidating rather than breaking out.
Street sentiment is constructive, with a Buy consensus and an average target around 360.2 versus a recent close in the low 320s. Recent target revisions have skewed higher across multiple firms, while the latest rating actions were mostly reiterations rather than downgrades.
The earnings profile favors another solid print, with Nordson beating estimates in 6 of the last 7 quarters. Next-year EPS is modeled higher at 12.9829 from 11.93833 for 2026, so shareholders should watch whether margin discipline and demand keep that upgrade path intact.
The tape shows net selling from discretionary trades, led by a director sale and an officer sale in recent months. Most of the larger filings are award, in-kind, or other non-discretionary transactions, so the signal is modest rather than a broad insider exodus.
Profitability remains strong, with a 55.4% gross margin, 27.2% operating margin, and 18.63% net margin. Growth is still healthy too, with revenue up 10.3% year over year and earnings up 23%, while free cash flow reached $777.2 million in fiscal 2025.
Nordson stands out for premium margins and steady execution in specialty industrial machinery, supported by recurring exposure to dispensing and precision systems. The valuation is not cheap, at 29.09 times earnings, but the setup reflects quality and consistency rather than deep cyclicality.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.11B
- P/E
- 30.94
- Fwd P/E
- 23.69
- PEG
- 1.28
- P/S
- 5.74
- P/B
- 5.24
- EV/EBITDA
- 19.86
- Div Yield
- 1.11%
- Gross Margin
- 55.29%
- Op Margin
- 26.88%
- Net Margin
- 18.63%
- ROE
- 17.59%
- ROIC
- 12.10%
Latest fiscal year · YoY change
- Revenue
- $2.79B+3.8%
- Gross Profit
- $1.54B+3.6%
- Op Income
- $724.27M
- Net Income
- $484.47M+3.7%
- EPS
- $8.56+4.8%
- OCF Growth
- +29.3%
- FCF Growth
- +34.4%
- 52W High
- $339.12
- 52W Low
- $228.44
- 50D MA
- $323.54
- 200D MA
- $298.49
- Beta
- 0.99
- RSI (14)
- 37
- Avg Volume
- 352.48K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Nordson posted record Q3 results with broad-based growth, a 35% backlog increase, and raised full-year guidance on strong demand in ATS and Medical.· August 20, 2026
- Q3 sales hit a record $818 million, up 10% year over year, with 12% organic growth across all three segments.
- Adjusted EPS was a record $3.25, up 19% year over year; EBITDA reached a record $262 million, or 32% of sales.
- Backlog rose 35% versus last year, with management saying order patterns remain normal and lead times have not elongated.
- Full-year guidance was raised to $3.035 billion-$3.075 billion of sales and $11.80-$12.00 adjusted EPS.
- ATS and Medical were the main drivers of the upside, while IPS remained steady around its long-term growth expectations.
Nordson reported third-quarter fiscal 2026 sales of $818 million, up 10% from $742 million a year ago, including 12% organic growth. Adjusted operating profit was a record $226 million, or 28% of sales; EBITDA was a record $262 million, or 32% of sales; and adjusted EPS was a record $3.25, up 19% from $2.73. GAAP net income was $153 million, or $2.73 per share. For the first nine months of fiscal 2026, management said revenue grew 9% and adjusted EPS grew 18% year over year. Full-year guidance was raised to sales of $3.035 billion to $3.075 billion and adjusted EPS of $11.80 to $12.00 per diluted share, with FX assumed neutral in Q4 and tax rate expected near 18%.
CEO Sundaram Nagarajan said the quarter reflected continued momentum from the first half, with all three segments contributing and growth end markets continuing to inflect. He emphasized Nordson’s Ascend Strategy and NBS Next framework, saying the company’s differentiated products, customer intimacy and niche market positioning are driving profitable growth. His tone was confident and constructive, especially on backlog, order entry and the strength of ATS and Medical heading into Q4 and beyond.
CFO Daniel Hopgood highlighted record sales of $818 million, adjusted operating profit of $226 million, EBITDA of $262 million and adjusted EPS of $3.25. He said net interest expense fell to $20 million due to stronger cash generation, lower borrowing costs and a newly launched commercial paper program, while free cash flow was $237 million with 144% conversion on net income excluding the noncash loss. He also noted cash on hand of $113 million, net debt of about $1.6 billion, leverage of 1.7x, and year-to-date returns of $137 million in dividends and $159 million in share repurchases, alongside $40 million of capital projects.
Analysts focused on the 35% backlog increase, asking whether lead times were stretching and what it implied for next year; management said there was no elongation, backlog typically turns over in about six months, and orders were still following normal recurring patterns. Questions also centered on why ATS drove so much of the raise and whether Medical was also accelerating; management said ATS and Medical were the two main upside drivers, with IPS more stable. Another set of questions addressed margins, tariffs and tax rate; management said tariff impact has not been material, margin targets remain unchanged, and an 18% tax rate is the long-term expectation.
The positive case from this call is that demand appears to be broadening, backlog is up 35%, and management says this strength is not being driven by abnormal order timing or longer lead times. ATS and Medical are accelerating, free cash flow remains strong, and the balance sheet gives Nordson room to keep buying back stock, pay dividends and pursue M&A.
The main caution is that ATS looks cyclical and management acknowledged it is at or near a peak growth phase, with next year expected to normalize toward mid-single-digit growth. IPS remains steady rather than exciting, and management said many opportunities there are more like small singles than large step-changes. They also flagged ongoing inflationary pressures tied to tariffs, freight and commodities, even if the direct tariff impact has not been material.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.2%
- Shares Outstanding
- 55.70M
- Float Shares
- 52.49M
of shares held by institutions
770 13F filers
Buy/sell ratio 3.67. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for NDSN, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Robert P. BresnahanHouse · PA08 | Sell | Apr 8, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | Feb 25, 25 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Sell | May 3, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 10, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Aug 3, 23 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Buy | Apr 3, 23 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Buy | Apr 3, 23 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Apr 11, 22 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Sell | Mar 29, 21 | Filing → |
| Van TaylorHouse · TX03 | Sell | Mar 25, 19 | Filing → |
| Thomas Charles MacArthurHouse · NJ03 | Sell | Dec 7, 18 | Filing → |
| Thomas Charles MacArthurHouse · NJ03 | Buy | Jun 7, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 6.26M | ▲ 186.48K |
| Blackrock, Inc. | 4.09M | ▼ 46.95K |
| Vanguard Capital Management LLC | 3.47M | ▲ 5.98K |
| State Street Corp | 3.05M | ▲ 73.72K |
| Vanguard Portfolio Management LLC | 2.30M | ▼ 55.63K |
| Geode Capital Management, LLC | 1.94M | ▲ 32.37K |
| Kayne Anderson Rudnick Investment Management LLC | 1.35M | ▼ 363.52K |
| Morgan Stanley | 1.34M | ▼ 77.80K |
| Invesco Ltd. | 1.33M | ▲ 13.90K |
| Fmr LLC | 823.14K | ▼ 17.25K |
| Aqr Capital Management LLC | 792.22K | ▲ 467.11K |
| Norges Bank | 715.04K | ▲ 715.04K |
Held by 1,341 ETFs
Biggest fund positions in NDSN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 1, 26 | JAEHNERT FRANK M | other | 583 |
| Nov 1, 26 | MAPES CHRISTOPHER L | other | 583 |
| Oct 30, 26 | MAPES CHRISTOPHER L | other | 43 |
| Nov 1, 26 | DeFord John A | other | 583 |
| Oct 30, 26 | DeFord John A | other | 77 |
| Oct 31, 26 | Kelley Joseph P | other | 1,481 |
| Oct 31, 26 | Subramanian Srinivas | other | 593 |
| Nov 1, 26 | MERRIMAN MICHAEL J | other | 583 |
| Nov 1, 26 | Morris Milton Mayo | other | 583 |
| Nov 1, 26 | JONES GINGER M | other | 583 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NDSN coverage
Recent articles, reports, and earnings notes.

Nordson (NDSN): Semiconductor Growth Meets Valuation Risk
Nordson delivered record fiscal Q3 2026 results with double-digit growth in its semiconductor-exposed segment and strong cash generation. The stock earns a Buy, but valuation and leverage keep upside measured.

Nordson's backlog jump proves this rally is being earned
Nordson's 35% year-over-year backlog growth gives its earnings rally a forward-demand engine, not just a higher multiple. Record Q3 sales, a 19% adjusted-EPS gain, and raised FY2026 guidance make NDSN the stronger industrial setup despite a premium valuation.

Nordson Corporation (NDSN) rises 7% on Q3 beat
Nordson Corporation (NDSN) rises after delivering a fiscal third-quarter earnings beat, raising full-year guidance and reporting a 35% backlog increase. The stock moved above its 52-week high on heavier-than-average volume, signaling strong investor confidence in the company’s growth and margin outlook.
Want a deeper read on NDSN?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Nordson EFD Launches PICO Pµlse XP HV Jetting System to Meet Assembly Market Demand for Dispensing High-Viscosity Materials
businesswire.com · Nov 9
Nordson Corporation Announces Earnings Release and Webcast for Fourth Quarter and Fiscal Year 2026
businesswire.com · Nov 6
3 Dividend Aristocrats With the Most Room to Keep Raising Their Dividends
247wallst.com · Nov 4
Nordson EFD to Preview New Dispensing Technologies for Medical Device Assembly at COMPAMED 2026
businesswire.com · Nov 2
Nordson Corporation Completes Acquisition of Contrinex, Expanding Its Industrial Sensing and Automation Portfolio
businesswire.com · Oct 23
5 Dividend Stocks That Turn Small Annual Raises Into Serious Long-Term Income
247wallst.com · Oct 9
Here's Why You Should Consider Investing in Nordson Stock Now
zacks.com · Oct 8
MWA or NDSN: Which Is the Better Value Stock Right Now?
zacks.com · Oct 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 18, 2026 · Live quote · Not investment advice